|
|
|
| Study on the prescription of Chinese Medical Code in the treatment of ulcerative colitis based on data mining |
| LI Pengfan1 LUO Yue2 ZHANG Yuli1 WANG Xueying1 CHEN Kanjun1 GU Sizhen1 DOU Danbo1 |
| 1.Department of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; 2.Yueyang Clinical Medical College, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China |
|
|
|
Abstract Objective To explore the characteristics and regularity of prescriptions for the treatment of ulcerative colitis in Chinese Medical Code. Methods Based on the traditional Chinese medicine inheritance support system, the drug frequency, drug properties and taste menstruation, association rules, prescription rules, core drug combinations in the treatment of “dysentery”, “intestinal dysentery”, “stagnation” and “diarrhea” in Chinese Medical Code were analyzed. Results Among the 341 prescriptions, 200 Chinese herbs were involved, including Radix Angelicae Sinensis, Rhizoma Coptidis, Radix Glycyrrhizae, Radix Aucklandiae, Radix Paeoniae Alba, and Poria. The drugs with neutral temperature, bitter taste and pungent taste were the most frequently used, followed by those with cold nature and sweet taste, those attributed to the spleen meridian were the highest, and those attributed to the stomach meridian were the second. The drug combinations with support ≥34 were 49 groups, the core drug combinations were 10 groups, and 5 new prescriptions were produced. Conclusion Through the traditional Chinese medicine inheritance support system, the prescription medication law of ulcerative colitis in Chinese Medical Code can be revealed to a certain extent, which is helpful to improve the curative effect of traditional Chinese medicine in the treatment of ulcerative colitis.
|
|
|
|
|
|
[1] Greuter T，Navarini A，Vavricka SR. Skin manifestations of inflammatory bowel disease [J]. Clin Rev Allergy Immunol，2017，53（3）：413-427.
[2] Ouyang Q. Advance in treatment of refractory inflammatory bowel disease [J]. Chin J Dig，2009，29（11）：783-786.
[3] Ungaro R，Mehandru S，Allen PB，et al. Ulcerative Colitis [J]. Lancet，2017，389（10080）：1756-1770.
[4] Ordás I，Eckmann L，Talamini M，et al. Ulcerative colitis [J]. Lancet，2012，380（9853）：1606-1619.
[5] 甄建华，黄光瑞.溃疡性结肠炎病因和发病机制的现代医学研究进展[J].世界华人消化杂志，2019，27（4）：245-251.
[6] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见（2018年，北京）[J].中华消化杂志，2018，38（5）：292-311.
[7] Guo BJ，Bian ZX，Qiu HC. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease [J]. Ann N Y Acad Sci，2017，1401（1）：37-48.
[8] 高旭东，谭静范，张莉.溃疡性结肠炎的中医治疗进展[J].当代医学，2017，23（33）：175-177.
[9] 裘沛然，邓铁涛，王永炎.中华医典[M/CD].长沙：湖南电子音像出版社，2014.
[10] 朱国福.中药学[M].北京：清华大学出版社，2012.
[11] 曲玉梅，王晓婷，庄颖梅，等.当归芍药散治疗溃疡性结肠炎的临床研究[J].临床心身疾病杂志，2015，21（Z1）：256-257.
[12] 刘琦，罗霞，罗爽，等.芍药苷通过抑制NLRP3炎症小体治疗溃疡性结肠炎小鼠的研究[J].中药新药与临床药理，2018，29（4）：409-414.
[13] 王文心.干姜的化学、药理及临床应用特点分析[J].中医临床研究，2016，8（6）：146-148.
[14] 惠陈敏，唐金婧，唐金涛，等.干姜及其提取物抗消化性溃疡的研究进展[J].吉林医药学院学报，2019，40（3）：218-221.
[15] 张明发，沈雅琴，朱自平，等.干姜温中止痛作用研究[J].西北药学杂志，1996（4）：186-189.
[16] 龙全江，徐雪琴.干姜化学成分、药理作用及加工炮制研究文献分析[J].现代中药研究与实践，2015，29（1）：82-83.
[17] 许青媛，于利森，张小利，等.干姜及其主要成分的抗凝作用[J].中国中药杂志，1991（2）：112-113.
[18] 吴佳伟.基于肠道菌群以及肠道屏障完整性探讨大黄酸治疗结肠炎症的作用机制[D].南京：南京中医药大学，2019.
[19] 王玉，杨雪，夏鹏飞，等.大黄化学成分、药理作用研究进展及质量标志物的预测分析[J].中草药，2019，50（19）：4821-4837.
[20] 梁晗业，徐志立，陶小军，等.五味子甲素对小鼠溃疡性结肠炎的治疗作用[J].中药药理与临床，2017，33（3）：38-42.
[21] 陈玲玲，陈熔杰.五味子乙素对溃疡性结肠炎模型大鼠的干预及作用机制研究[J].中国药师，2018，21（11）：1941-1945. |
|
|
|
